SCHEMBL799846

SCHEMBL799846

COc1ccc(OC)c(C(C)(C)C)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.70
GAA P10253 1/20 0.70
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
CA12 O43570 1/20 0.58
CA7 P43166 1/20 0.58
CA9 Q16790 1/20 0.58
CA14 Q9ULX7 1/20 0.58
MAPT P10636 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
THRB P10828 1/20 0.50
CYP3A4 P08684 2/20 0.48
HPGD P15428 2/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
ALOX15 P16050 1/20 0.48
RARA P10276 1/20 0.47
RARB P10826 1/20 0.47
RARG P13631 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28499495 0.89 ALDH1A1 (0.58) ALDH1A1GAACA1CA2CA12
SCHEMBL1725843 0.88 ALDH1A1 (0.57) ALDH1A1GAACA1CA2CA12
SCHEMBL252044 0.84 ALDH1A1 (0.54) ALDH1A1GAACA1CA2CA12
SCHEMBL5827713 0.84 ALDH1A1 (0.54) ALDH1A1GAACA1CA2CA12
SCHEMBL30379901 0.84 ALDH1A1 (0.54) ALDH1A1GAACA1CA2CA12
Butylated Hydroxyanisole SCHEMBL29354314 0.83 ALDH1A1 (1.00) ALDH1A1GAACA1CA2CA12
SCHEMBL28110284 0.83 ALDH1A1 (1.00) ALDH1A1GAACA1CA2CA12
Butylated Hydroxyanisole SCHEMBL30330 0.83 ALDH1A1 (1.00) ALDH1A1GAACA1CA2CA12
SCHEMBL15164795 0.83 ALDH1A1 (0.57) ALDH1A1GAACA1CA2CA12
SCHEMBL18430725 0.83 ALDH1A1 (0.57) ALDH1A1GAACA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514477-A1 FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE Firmenich SA (CH) 2025-03-05 EP claimed
CN-119486703-A Fragrance composition with lasting fragrance appearance 弗门尼舍有限公司 2025-02-18 CN claimed
EP-1733450-B1 REDOX SHUTTLE FOR RECHARGEABLE LITHIUM-ION CELL 3M INNOVATIVE PROPERTIES CO (US) 2010-12-08 EP claimed
US-20100297215-A1 COMPOSITIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-11-25 US claimed
US-7811710-B2 Redox shuttle for rechargeable lithium-ion cell 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-10-12 US claimed
EP-1733450-A2 REDOX SHUTTLE FOR RECHARGEABLE LITHIUM-ION CELL 3M Innovative Properties Company (US) 2006-12-20 EP claimed
WO-2005099024-A2 REDOX SHUTTLE FOR RECHARGEABLE LITHIUM-ION CELL 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-10-20 WO claimed
US-20050221196-A1 Redox shuttle for rechargeable lithium-ion cell 3M INNOVATIVE PROPERTIES COMPANY 2005-10-06 US claimed
US-12497577-B2 Method of countering malodour in a washing machine comprising the addition of a fragrance precursor GIVAUDAN SA (CH) 2025-12-16 US disclosed
CN-120092027-A Monomer composition, methacrylic resin composition, method for producing same, and resin molded article 三菱化学株式会社 2025-06-03 CN disclosed
CN-119948071-A Composition containing ester compound, process for producing the same, polymerizable composition, and process for producing (meth) acrylic polymer 三菱化学株式会社 2025-05-06 CN disclosed
CN-119923418-A Methacrylic acid-containing composition, method for producing methacrylic acid ester, polymerizable composition, and method for producing methacrylic acid polymer 三菱化学株式会社 2025-05-02 CN disclosed
EP-4514477-A1 FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE Firmenich SA (CH) 2025-03-05 EP disclosed
CN-119562975-A Composition containing ester compound and method for producing same, polymerizable composition, (meth) acrylic polymer, and method for producing same 三菱化学株式会社 2025-03-04 CN disclosed
EP-0430055-A1 2-tert.-butyl-p-benzoquinone-tetraalkyl-ketals and their preparation BASF Aktiengesellschaft (DE) 1991-06-05 EP disclosed
US-4631252-A PHOTOGRAPHIC STABILIZERS CIBA-GEIGY AG (CH) 1986-12-23 US disclosed
US-4616082-A PHOTOGRAPHIC STABILIZERS CIBA-GEIGY AG (CH) 1986-10-07 US disclosed
US-4549015-A PHOTOHRAPHIC STABILIZERS CIBA-GEIGY AG (CH) 1985-10-22 US disclosed
EP-0098241-B1 HYDROQUINONE ETHERS AND A PROCESS FOR PREPARING THEM CIBA-GEIGY AG (CH) 1985-10-02 EP disclosed
EP-0098241-A1 Hydroquinone ethers and a process for preparing them CIBA-GEIGY AG (CH) 1984-01-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297215-A1 COMPOSITIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY UNG, GSTK1, GSTA1 ALDH1A1 165/4885GAA 782/4885CA1 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.